BH

Bertrand Heckmann

GN Galapagos Nv: 9 patents #22 of 177Top 15%
GS Galapagos Sasu: 4 patents #1 of 8Top 15%
HR Hoechst Marion Roussel: 4 patents #35 of 309Top 15%
RU Roussel Uclaf: 3 patents #127 of 430Top 30%
AS Aventis Pharma S.A.: 1 patents #304 of 591Top 55%
UN Unknown: 1 patents #29,356 of 83,584Top 40%
Overall (All Time): #194,775 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11072611 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Nicolas Desroy, Reginald Christophe Xavier Brys, Agnès Marie JONCOUR, Christophe Peixoto, Xavier Marie Bock 2021-07-27
10526329 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Nicolas Desroy, Reginald Christophe Xavier Brys, Agnès Marie JONCOUR, Christophe Peixoto, Xavier Marie Bock 2020-01-07
10125132 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Nicolas Desroy, Reginald Christophe Xavier Brys, Agnès Marie JONCOUR, Christophe Peixoto, Xavier Marie Bock 2018-11-13
9796719 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Nicolas Desroy, Reginald Christophe Xavier Brys, Agnès Marie JONCOUR, Christophe Peixoto, Xavier Marie Bock +1 more 2017-10-24
9670204 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Nicolas Desroy, Reginald Christophe Xavier Brys, Agnès Marie JONCOUR, Christophe Peixoto, Xavier Marie Bock 2017-06-06
9249141 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Nicolas Desroy, Reginald Christophe Xavier Brys, Agnès Marie JONCOUR, Christophe Peixoto, Xavier Marie Bock 2016-02-02
8993590 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders Nicolas Desroy, Reginald Christophe Xavier Brys, Agnès Marie JONCOUR, Christophe Peixoto, Xavier Marie Bock 2015-03-31
8765766 Pyrimidine derivatives which are antagonists of the vitronectin receptor Jean-Michel Lefrancois 2014-07-01
8133896 Pyrimidine derivatives which are antagonist of the vitronectin receptor Jean-Michel Lefrancois 2012-03-13
7846932 Methods for the use of pyrimidine derivatives which are antagonists of vitronectin receptor Jean-Michel Lefrancois 2010-12-07
7825119 Pyrimidine derivatives which are antagonists of vitronectin receptor Jean-Michel Lefrancois 2010-11-02
7763621 Vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same Jean-Marie Ruxer, Jean-Michel Lefrancois 2010-07-27
7582640 Vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same Jean-Marie Ruxer, Jean-Michel Lefrancois 2009-09-01
6313101 Derivatives of erythromycin, their preparation process and their use as medicaments Alexis Denis, Claude Fromentin 2001-11-06
6143774 Imidazole n-benzyldioxol derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists Simone Jouquey, Jean-Paul Vevert, Jidong Zhang 2000-11-07
5986103 2-alkyl-1H-imidazole-5-carboxylic acids Simone Jouquey, Jean-Paul Vevert, Jidong Zhang 1999-11-16
5977155 Imidazole-5-carboxamides Alain Corbier, Pierre Deprez, Michel Fortin, Jacques Guillaume 1999-11-02
5932741 Imidazole-5-carboxylic acid compounds Jean-Paul Vevert, Jidong Zhang 1999-08-03
5856509 Derivatives of imidazole, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them Jean-Paul Vevert, Jidong Zhang 1999-01-05
5811444 Compositions for reducing abnormal stimulation of endothelin receptors and novel compounds Jean-Paul Vevert, Jidong Zhang 1998-09-22
5807878 Tetrasubstituted imidazoles Alain Corbier, Pierre Deprez, Michel Fortin, Jacques Guillaume 1998-09-15
5674883 Derivatives of pyridone, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them Michel Fortin, Jean-Luc Haesslein 1997-10-07